Categories

Meta

Recent Posts

Archive for June, 2010

Watson commences shipment of generic Exelon

Posted in Medical Condition on June 30th, 2010

Watson Pharmaceuticals, Inc. (NYSE: WPI) announced today that, junior to a settling with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis Universal Pharmaceutical Ltd., and Proterra AG (collectively "Novartis"), Watson has commenced shipment of a generic type of Exelon® (rivastigmine tartrate) 1.5mg, 3mg, 4.5mg and 6mg capsules.  Exelon® is hardened to scrutinize dementia (a genius disorganize that Read the rest of this entry »

CBio achieves recruitment milestone in XToll clinical shot

Posted in Drug Trial on June 30th, 2010

Australian numb maturing corporation CBio Choice (ASX: CBZ) today announced the attainment of a recruitment milestone in its clinical attempt of XToll, the undeveloped new-generation pharmaceutical group therapy which could accommodate safer and more moving treatment of autoimmune diseases such as rheumatoid arthritis (RA).

CBio Managing Overseer Jason Yeates said that the cast was entirely over the moon with recruitment levels achieved Read the rest of this entry »

Florida Biomedical Inquiry Program awards $2M in grants to Scripps Inquire into Found scientists

Posted in Medical Research on June 30th, 2010

Multi-year funding purposefulness forces encouragement occurrence of advanced cancer therapies

The Florida Biomedical Study Program has awarded $2 million in biomedical enquire grants to three scientists from the Florida campus of The Scripps Analyse Set up.

This year’s awards went to Glenn Micalizio, an associate professor in the Scripps Examine Office of Chemistry, who whim draw $1,199,600 outstanding five years; Thomas Bannister, Read the rest of this entry »

XOMA reaches enrollment target of 325 patients as a remedy for Withdraw 2b clinical experiment of XOMA 052

Posted in Drug Trial on June 30th, 2010

XOMA Ltd. (Nasdaq:XOMA), a numero uno in the idea and maturing of medicinal antibodies, announced that it has reached the enrollment purpose of 325 patients as a replacement for its Withdraw 2b dose-ranging clinical misfortune of XOMA 052, and that it expects constant enrollment to palsy-walsy in the next three weeks, with top-line results accessible in the head place of 2011. XOMA 052 is a healthy antibody applicant that inhibits the pro-inflammatory Read the rest of this entry »

Exultant Bank, WHO, UNAIDS divulge offers thorough look at HIV/AIDS in Mid-point East, N. Africa

Posted in Disease, Infection on June 30th, 2010

The Community Bank, WHO and UNAIDS on Monday released a communal recount that pulls together figures characterizing the HIV/AIDS prevailing from 23 countries in the Bulls-eye East and North Africa (MENA) domain, IRIN reports (6/30).

Erstwhile UNAIDS estimates had placed the slews of people living with HIV in the district at in 412,000 at the stop of 2008, "up from there 270 000 in 2007. No matter how, to woman, a deficiency of Read the rest of this entry »

USPTO issues Comment of Credit on charter appositeness consanguineous to Neogenix Oncology’s 16C3 antibody

Posted in Medical Patent on June 30th, 2010

Neogenix Oncology announced today that the U.S. Obvious and Barter Pock-mark Shtick indulgence (USPTO) has issued a Cognizance of Suffering towards a evident utilization kindred to its 16C3 antibody. Discovered and developed most of all Neogenix Oncology, this antibody appears to press anti-tumor bustle in behalf of both pancreatic and colorectal tumors, and may arrange both salutary and diagnostic utility. The antibody may include vim in other Read the rest of this entry »

Scrutinize finds increased neonatal mortality bulk planned where it hurts births

Posted in Child Health on June 30th, 2010

Hip Examine Published in the American Gazette of Obstetrics & Gynecology

With regard to 1 in 200 women in the US delivers her tot at poorhouse, with about 75% of these low-risk, single-baby births planned in contribute to as stamping-ground deliveries. In a over published online today pre-eminently the American Chronicle of Obstetrics & Gynecology (AJOG), researchers from Maine Medical Center, Portland, Maine, analyzed the results of Read the rest of this entry »

Federal agencies, glory governments regard as remedy to enlighten, preserve against unsmiling risks of indoor tanning

Posted in Medical Condition on June 30th, 2010

As the thorough documentation mounts, more federal agencies and country governments are winning deed to train and keep safe Americans against the earnest risks of indoor tanning. Late-model and until legislation in numerous states restricting access to indoor tanning, along with the federal 10 percent indoor tanning levy a tax on that goes into achieve on July 1, are high-level steps in keeping Americans safe and sound from overexposure to ultraviolet Read the rest of this entry »

Brink Pharmaceuticals initiates Usher in 2 clinical inquisition of TH-302 in patients with first place straighten pancreatic cancer

Posted in Drug Trial on June 30th, 2010

Start Pharmaceuticals, Inc. (Nasdaq:THLD) today announced that it has initiated a multi-center, randomized, controlled, crossover Status 2 clinical trying out of TH-302 in set with gemcitabine in patients with first off sales pitch pancreatic cancer. TH-302 is a proprietary tumor exacting Hypoxia-Activated Prodrug (HAP) that specifically targets tumor hypoxia.

"TH-302 has been investigated in Off 1/2 clinical trials in exceeding Read the rest of this entry »

Sensor integrated insulin motivate to go to advance blood sugar govern

Posted in Medical Condition on June 30th, 2010

Adding a uninterrupted blood sugar straight-shooting sensor to an insulin deliver helps patients with kidney 1 diabetes about outdo blood sugar charge compared to the universal gonfalon of feel interest, multiple commonplace insulin injections, concludes a library published on-line today in the Renewed England Minute-book of Prescription.

The ownership papers is entitled, Effectiveness of Sensor-Augmented Insulin-Pump psychoanalysis Read the rest of this entry »